Literature DB >> 26828052

Bedaquiline and multidrug-resistant tuberculosis: a systematic and critical analysis of the evidence.

Emanuele Pontali1, Giovanni Sotgiu2, Lia D'Ambrosio3, Rosella Centis4, Giovanni Battista Migliori4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26828052     DOI： 10.1183/13993003.01891-2015

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  27 in total

1.  Classification of drugs to treat multidrug-resistant tuberculosis (MDR-TB): evidence and perspectives.

Authors:  Adrian Rendon; Simon Tiberi; Anna Scardigli; Lia D'Ambrosio; Rosella Centis; Jose A Caminero; Giovanni Battista Migliori
Journal:  J Thorac Dis       Date:  2016-10       Impact factor: 2.895

2.  Emergence of mmpT5 Variants during Bedaquiline Treatment of Mycobacterium intracellulare Lung Disease.

Authors:  David C Alexander; Ravikiran Vasireddy; Sruthi Vasireddy; Julie V Philley; Barbara A Brown-Elliott; Benjamin J Perry; David E Griffith; Jeana L Benwill; Andrew D S Cameron; Richard J Wallace
Journal:  J Clin Microbiol       Date:  2016-12-07       Impact factor: 5.948

Review 3.  Surgery and pleuro-pulmonary tuberculosis: a scientific literature review.

Authors:  Dragan Subotic; Piotr Yablonskiy; Giorgia Sulis; Ioan Cordos; Danail Petrov; Rosella Centis; Lia D'Ambrosio; Giovanni Sotgiu; Giovanni Battista Migliori
Journal:  J Thorac Dis       Date:  2016-07       Impact factor: 2.895

Review 4.  Delamanid and bedaquiline to treat multidrug-resistant and extensively drug-resistant tuberculosis in children: a systematic review.

Authors:  Lia D'Ambrosio; Rosella Centis; Simon Tiberi; Marina Tadolini; Margareth Dalcolmo; Adrian Rendon; Susanna Esposito; Giovanni Battista Migliori
Journal:  J Thorac Dis       Date:  2017-07       Impact factor: 2.895

Review 5.  Transmission of drug-resistant tuberculosis in HIV-endemic settings.

Authors:  Palwasha Y Khan; Tom A Yates; Muhammad Osman; Robin M Warren; Yuri van der Heijden; Nesri Padayatchi; Edward A Nardell; David Moore; Barun Mathema; Neel Gandhi; Vegard Eldholm; Keertan Dheda; Anneke C Hesseling; Valerie Mizrahi; Roxana Rustomjee; Alexander Pym
Journal:  Lancet Infect Dis       Date:  2018-12-13       Impact factor: 25.071

6.  Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline.

Authors:  Payam Nahid; Sundari R Mase; Giovanni Battista Migliori; Giovanni Sotgiu; Graham H Bothamley; Jan L Brozek; Adithya Cattamanchi; J Peter Cegielski; Lisa Chen; Charles L Daley; Tracy L Dalton; Raquel Duarte; Federica Fregonese; C Robert Horsburgh; Faiz Ahmad Khan; Fayez Kheir; Zhiyi Lan; Alfred Lardizabal; Michael Lauzardo; Joan M Mangan; Suzanne M Marks; Lindsay McKenna; Dick Menzies; Carole D Mitnick; Diana M Nilsen; Farah Parvez; Charles A Peloquin; Ann Raftery; H Simon Schaaf; Neha S Shah; Jeffrey R Starke; John W Wilson; Jonathan M Wortham; Terence Chorba; Barbara Seaworth
Journal:  Am J Respir Crit Care Med       Date:  2019-11-15       Impact factor: 21.405

7.  Target regimen profiles for treatment of tuberculosis: a WHO document.

Authors:  Christian Lienhardt; Payam Nahid; Michael L Rich; Cathy Bansbach; Emily A Kendall; Gavin Churchyard; Lice González-Angulo; Lia D'Ambrosio; Giovanni Battista Migliori; Mario Raviglione
Journal:  Eur Respir J       Date:  2017-01-25       Impact factor: 16.671

8.  Bedaquiline for the Treatment of Multidrug-resistant Tuberculosis in the United States.

Authors:  Sundari Mase; Terence Chorba; Samuel Parks; Ann Belanger; Felicia Dworkin; Barbara Seaworth; Jon Warkentin; Pennan Barry; Neha Shah
Journal:  Clin Infect Dis       Date:  2020-08-14       Impact factor: 9.079

Review 9.  New Antibiotics for Multidrug-Resistant Bacterial Strains: Latest Research Developments and Future Perspectives.

Authors:  Marco Terreni; Marina Taccani; Massimo Pregnolato
Journal:  Molecules       Date:  2021-05-02       Impact factor: 4.411

10.  Improving the Potency of N-Aryl-2,5-dimethylpyrroles against Multidrug-Resistant and Intracellular Mycobacteria.

Authors:  Meir Touitou; Fabrizio Manetti; Camila Maringolo Ribeiro; Fernando Rogerio Pavan; Nicolò Scalacci; Katarina Zrebna; Neelu Begum; Dorothy Semenya; Antima Gupta; Sanjib Bhakta; Timothy D McHugh; Hanoch Senderowitz; Melina Kyriazi; Daniele Castagnolo
Journal:  ACS Med Chem Lett       Date:  2019-12-10       Impact factor: 4.345
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.